In 129 enrolled patients, lymph node metastasis, large tumor size, low Hb level, and AURKA overexpression were prognostic factors for both recurrent free survival (RFS) and overall survival (OS) in univariate analysis. The gene discussed is GSTM1; the disease is metastatic malignant neoplasm in the lymph nodes.